Medicine
Asceniv 5 g/50 mL injection
Asceniv 5 g/50 mL injection is a prescription medicine containing Human immunoglobulin g for intravenous use, marketed by ADMA Biologics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at 2 to 8°C (36 to 46°F) for up to 36 months from the date of…
Key facts
- Active ingredient (INN)
- Human immunoglobulin g
- Brand
- Asceniv
- Strength
- 5 g/50 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 50 mL
- Marketing authorisation holder
- ADMA Biologics
- Manufacturer
- ADMA Biologics
- Origin register
- US FDA, United States
- Storage
- Store at 2 to 8°C (36 to 46°F) for up to 36 months from the date of manufacture. Do not freeze. Product may be stored up to 4 weeks at ≤ 25° C (77° F). After storage at room temperature product must be used or discarded.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J06BA02 Human immunoglobulin g
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2019
- Identifiers
- RxCUI 2123037, 2123042DailyMed set ID d74f4360-3b51-496c-96fb-84c3976958d2NDC 69800-0250Application BLA125590
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 50 mL in 1 vial, single-use | 69800-0250-1 | ADMA Biologics | 1 April 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Human immunoglobulin g 5 g/50 mL injection.
- Yimmugo 5 g/50 mL injectionAvailable on requestBiotestUS FDA2 packs Cold chain
- Bivigam 5 g/50 mL injectionAvailable on requestADMA BiologicsUS FDA1 pack Cold chain
- Gammaked 5 g/50 mL injectionAvailable on requestKedrion BiopharmaUS FDA1 pack
- Gammaplex 5 g/50 mL injectionAvailable on requestBio Products LaboratoryUS FDA1 pack
- Gamunex-C 5 g/50 mL injectionAvailable on requestGrifolsUS FDA1 pack
- Gamunex-C 5 g/50 mL injectionAvailable on requestGrifolsUS FDA1 pack
Other strengths and forms of Human immunoglobulin g
Clinical summary
Human immunoglobulin g is a human immunoglobulin G indicated for the treatment of adults and pediatric patients 2 years of age and older with primary humoral immunodeficiency (PI). MedsAcross supplies Human immunoglobulin g for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Human immunoglobulin gFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BIVIGAM prescribing information (ADMA Biologics) · U.S. National Library of Medicine, DailyMed
Need Asceniv 5 g/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.